Australia Tuberculosis Therapeutics Market Size & Outlook
Australia tuberculosis therapeutics market, 2018-2030 (US$M)
Related Markets
Australia tuberculosis therapeutics market highlights
- The Australia tuberculosis therapeutics market generated a revenue of USD 118.8 million in 2023 and is expected to reach USD 168.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, active tb was the largest revenue generating disease type in 2023.
- Active TB is the most lucrative disease type segment registering the fastest growth during the forecast period.
Tuberculosis therapeutics market data book summary
| Market revenue in 2023 | USD 118.8 million |
| Market revenue in 2030 | USD 168.5 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Active tb |
| Fastest growing segment | Active TB |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Active TB, Latent TB |
| Key market players worldwide | AstraZeneca PLC, Johnson & Johnson, Eli Lilly and Co, Viatris Inc, Teva Pharmaceutical Industries Ltd, Sanofi SA, Novartis AG ADR, Sun Pharmaceutical Industries, Pfizer Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 5.6% of the global tuberculosis therapeutics market in 2023.
- Country-wise, India is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India tuberculosis therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 429.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tuberculosis Therapeutics Market Scope
Tuberculosis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia tuberculosis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tuberculosis therapeutics market will help companies and investors design strategic landscapes.
Active tb was the largest segment with a revenue share of 69.11% in 2023. Horizon Databook has segmented the Australia tuberculosis therapeutics market based on active tb, latent tb covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia tuberculosis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia tuberculosis therapeutics market databook
-
Our clientele includes a mix of tuberculosis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia tuberculosis therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Australia tuberculosis therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia tuberculosis therapeutics market size, by disease type, 2018-2030 (US$M)
Australia Tuberculosis Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
